[Molecular diagnosis and therapy in surgery].
Efficiency and economy is surgical research exemplified in molecular diagnostics and therapy must be looked upon from two view points: 1.) The efficiency of molecular diagnostics is relatively easy to assess. It is more difficult to prove the therapeutic consequences of new knowledge. To achieve this, long-term observations for 3-5 years are necessary. This fact underlines the difficulties in clinical research linearly consuming more time and efforts compared with basic research. Economists in surgical research must pursue the aim to bring a procedure to clinical application having it financed by the insurance companies. This involves a long-term approach. Several financing schemes are included in a step-wise approach: Third parties for basic research, resources for clinical studies from the appreciate institutions, co-operation with industrial partners for the evolving clinical application and lastly the clinical recognition by the health care organisations.
Herfarth
C
C
Chirurgische Universitätsklinik, Heidelberg.
D003362:Cost-Benefit Analysis; D005380:Financing, Government / Q000639:trends; D005544:Forecasting; D013502:General Surgery / Q000191:economics*; D005821:Genetic Techniques / Q000191:economics*; D015316:Genetic Therapy / Q000191:economics*; D005858:Germany; D006801:Humans; D010348:Patient Care Team / Q000191:economics*; D012109:Research Support as Topic / Q000191:economics*
Molekulare Diagnostik und Therapie in der Chirurgie.